Epidemiology and transmission of drug resistance mutations among treatment-naïve people living with HIV-1 in Israel, 2010-2018 - Tali Wagner

European Meeting on HIV & Hepatitis 2021

Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019 - Karol Serwin

European Meeting on HIV & Hepatitis 2021

Assessment of HIV-1 DNA quantification methods in the Italian HIV DNA Network - Ilaria Vicenti

European Meeting on HIV & Hepatitis 2021

Nervous system pathology of HIV-positive people in the large industrial center within the Russian Federation: epidemiological analysis - Viktoria Sotskova

European Meeting on HIV & Hepatitis 2021

AIDS mortality and lethality in Minsk, Belarus - Marharyta Shylava

European Meeting on HIV & Hepatitis 2021

Co-infections with hepatitis virus B and C among patients with human immunodeficiency virus in a regional center of HIV/AIDS from northeastern Romania - Cristina Sapaniuc

European Meeting on HIV & Hepatitis 2021

Molecular Epidemiology Analysis Reveals Actively Growing Transmission Clusters in the Polyphyletic HIV-1 Infection in Cyprus (2019-2020) - Cicek Topcu

European Meeting on HIV & Hepatitis 2021

Hepatitis C virus treatment response to sofosbuvir/ledipasvir among adolescents coinfected with HIV and HCV: Real world data from Ukraine - Farihah Malik

European Meeting on HIV & Hepatitis 2021

Pharmacist-led telephone clinic is an effective strategy for treating patients with hepatitis C and removing barriers to attending appointments - Andrew Sommerville

European Meeting on HIV & Hepatitis 2021

Frequency of IN gene region polymorphisms associated with ALLINIs effectiveness in HIV-1 subtype A6 dominating in Russia - Ilya Lapovok

European Meeting on HIV & Hepatitis 2021

Pretreated drug-resistance in newly diagnosed HIV-1 patients in Portugal between 2014 and 2019 - Marta Pingarilho

European Meeting on HIV & Hepatitis 2021

Application of the genetic diversity analysis for determination of HIV infection duration - Anastasia Murzakova

European Meeting on HIV & Hepatitis 2021

Integrase genotyping is highly effective on diverse HIV-1 non-B clades circulating in Cameroon: toward a successful transition to Dolutegravir-based regimens in Africa - Ezechiel Ngoufack Jagni Semengue

European Meeting on HIV & Hepatitis 2021

Comparison of the new Cepheid HIV VL XC Assay with the established Abbott Alinity m in HIV-1 viral load measurement - Robert Ehret

European Meeting on HIV & Hepatitis 2021

A Public Health Approach to Sustainability of Community Based HCV Treatment among HIV/HCV Co-infected KPs through programmatic cost efficiency in Ukraine - Zahedul Islam

European Meeting on HIV & Hepatitis 2021

Sensitivity of ultra-deep sequencing for dual HIV infection detection - Darya Saleeva

European Meeting on HIV & Hepatitis 2021

A Multi-Allelic Molecular-Beacon-Based Real-Time RT-PCR Assay for the Detection of the Coronavirus SARS-CoV-2 from Clinical Samples - Andreas Chrysostomou

European Meeting on HIV & Hepatitis 2021

Use of Fibroquel® (type I polymerized collagen) in patients with hypoxemic inflammatory pneumonia secondary to COVID-19 in Veracruz, Mexico. - Luis Del Carpio-Orantes

European Meeting on HIV & Hepatitis 2021

PK-virological algorithm to target risk of resistance among key populations in Togo - Valentine Ferré

European Meeting on HIV & Hepatitis 2021

Longitudinal Evaluation of Sequencing Quality in EQA-Schemes from 2014 to 2020 - Marcel Schuetze

European Meeting on HIV & Hepatitis 2021

APACC 2021

Amnestic Neurocognitive Impairment in Older Adults Living with HIV with Immune Recovery Following Delayed Antiretroviral Treatment in Northern Thailand

APACC 2021

Association between the levels of serum free testosterone levels and lifestyle-related diseases in people living with HIV

APACC 2021

Immune profile of COVID-19 patients treated with corticosteroids vs anti-interleukin 6 {tocilizumab) for cytokine release syndrome.

APACC 2021